McIlrath & Eck »

Cyclacel Pharmaceuticals shares owned by McIlrath & Eck

Quarter-by-quarter ownership of Cyclacel Pharmaceuticals (CYCC) shares owned by McIlrath & Eck from 13F filings

Historical chart of McIlrath & Eck investment in Cyclacel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Cyclacel Pharmaceuticals held by McIlrath & Eck consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cyclacel Pharmaceuticals by McIlrath & Eck

Quarter filed Position value Share count Share price at filing
2024-09-30 $164 166 0.99
2024-03-31 $1.8k 832 2.11
2023-12-31 $2.2k 832 2.67

More positions owned by McIlrath & Eck

Vanguard Index Fds Growth Etf (VUG)
Ea Series Trust Strive Total Ret (STXT)
Microsoft Corporation (MSFT)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
American Centy Etf Tr Avantis Us Mid C (AVMC)
Ea Series Trust Strive Enhanced (BUXX)
Vanguard Index Fds Large Cap Etf (VV)
Capital Grp Fixed Incm Etf T Short Duration (CGSD)
Vanguard Index Fds Value Etf (VTV)
Fidelity Covington Trust High Divid Etf (FDVV)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Ea Series Trust Strive Emerging (STXE)
Invesco Exchange Traded Fd T Ftse Rafi 1000 (PRF)
Vanguard Index Fds Real Estate Etf (VNQ)
Vanguard Index Fds Mid Cap Etf (VO)

View all positions for McIlrath & Eck

Top funds holding Cyclacel Pharmaceuticals

Armistice Capital
Point72 Asset Management
Acadian Asset Management
Geode Capital Management
Tower Research Capital
McIlrath & Eck
Activest Wealth Management
Advisor Group Holdings
Morgan Stanley
Wells Fargo & Company
Signature
Bank of America Corporation
Harbour Investments
Qube Research & Technologies

View all funds holding Cyclacel Pharmaceuticals